Insulet Corp. Stock Rises 6.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Insulet Corp. rallied 6.0% to $148.03 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.7% to 7,691.76 and Dow Jones Industrial Average falling 0.2% to 53,343.40.

The stock's rise snapped a two-day losing streak.

Insulet Corp. closed 58.3% below its 52-week high of $354.88, which the company achieved on November 20th.

The stock outperformed some of its peers, as Eli Lilly & Co. rose 3.6% to $1,225.73, DexCom Inc. rose 0.9% to $89.60, and Johnson & Johnson rose 3.33% to $271.11.

Trading volume totaled 1.6 million, compared to the 50-day average of 1.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 18, 2026 16:34 ET (20:34 GMT)